Florida Dialysis Providers Facing Federal Investigations Over ESRD Treatment Billing
Dialysis clinics may submit hundreds of Medicare claims each week, each tied to treatments that follow recurring schedules and standardized workflows. That volume leaves behind a dense record of scheduled sessions, completed treatments, and Medicare claims. When federal authorities believe treatment records do not match the services reported, routine ESRD billing can quickly turn into allegations that claims were inflated, misclassified, or submitted for dialysis that never occurred.
A federal inquiry may begin with a mismatch between the treatment log and the claim submitted for that date. Treatment logs, machine records, and Medicare claims may tell different versions of the same day. Early guidance from an experienced Florida healthcare fraud lawyer can help determine where those records diverge and whether the discrepancy reflects fraud or a breakdown in how treatment and billing information moved through the facility.
A Dialysis Claim Represents More Than a Scheduled Appointment
Medicare pays ESRD facilities under a bundled, per-treatment system for outpatient maintenance dialysis. The payment includes the dialysis treatment along with many drugs, laboratory services, supplies, and other renal dialysis services furnished as part of that care.
The schedule may show a full session even though the patient arrived late, left early, refused treatment, or experienced a complication that stopped dialysis. Those events can affect both the clinical record and the claim eventually submitted.
Claims data may still make the session look complete even when the clinical record tells a more complicated story. Chair records, nursing documentation, and treatment notes can show when dialysis was interrupted, shortened, or never started. Those details can explain why the billing record and the clinical timeline do not line up perfectly.
Machine Data Can Tell a Different Story From the Treatment Note
Modern dialysis machines record treatment duration, blood flow, alarms, interruptions, and other technical information. Those records can become central when prosecutors question whether a billed session was fully performed.
A nursing note may state that dialysis occurred while machine data reflects an abbreviated treatment or prolonged interruption. That difference can be portrayed as evidence that the claim overstated the service.
A shortened machine record may reflect a device change, an interruption, or treatment completed under a second machine. Matching the technical record to the correct patient, chair, and date can reveal whether the apparent gap reflects incomplete care or simply how the session was documented. Without that matching process, machine data can be given more weight than the full treatment record supports.
Missed and Shortened Sessions Can Create Billing Disputes
Dialysis patients do not always complete the treatment originally planned. Transportation problems, hypotension, access complications, illness, or patient refusal may shorten or cancel a session.
Problems arise when the schedule, nursing record, and billing system capture different versions of the same session. A claim generated from the original appointment may remain in the system even after the clinical record shows that treatment ended early or never began.
Repeated mismatches can look intentional when reviewed across hundreds of claims. Patient-level records can show whether the discrepancy arose from the events of that day or from a billing process that failed to capture changes made after scheduling.
ESRD Reimbursement Classifications Can Expand the Investigation
Certain ESRD claims receive adjustments or additional payment when qualifying conditions are met. Higher reimbursement can draw scrutiny when those classifications appear repeatedly across the same provider or patient population.
CMS’s ESRD payment system allows specified adjustments and outlier payments, but the claim still has to reflect the patient’s actual treatment and documented circumstances. A classification that looks improper on the claim may have originated with billing personnel interpreting clinical information supplied by someone else.
Administrative coding decisions can later be attributed to a physician or medical director even when clinical personnel never selected the reimbursement category. Emails, coding notes, and workflow records can show who made that choice, what information was available, and whether the physician ever saw the classification before submission.
Consolidated Billing Can Create Allegations of Improper Separate Claims
Separate claims for services Medicare considers part of the ESRD bundle can draw immediate scrutiny. Laboratory testing, drugs, supplies, and other dialysis-related services may appear improper when billed outside the facility payment, while services unrelated to ESRD can present a different reimbursement question.
Laboratory testing is one common pressure point because the same patient may receive tests related to dialysis and tests ordered for another medical condition. The diagnosis, ordering record, and reason for the service can show why separate billing occurred.
A laboratory result viewed only through the ESRD claim history may appear duplicative even when it addressed a condition outside dialysis care. The ordering diagnosis, timing, and treatment note may show why the service was separate from the dialysis bundle. That context can change whether the claim looks like improper duplicate billing or a distinct service tied to another medical need.
Treatment Records Can Become Evidence of Services Never Performed
Claims for dialysis allegedly never performed create some of the most serious exposure. Federal prosecutors may compare patient attendance, machine records, transportation logs, staffing schedules, and medical notes to identify dates when the billed treatment appears to have no supporting clinical record.
A missing note does not automatically mean the patient was not treated. Documentation may have been stored in another system, entered under an incorrect date, or lost during a transition between electronic records platforms.
A repeated absence of clinical support presents a different problem. Claims continuing after a patient was hospitalized, transferred, or no longer receiving treatment at the facility may be used to argue that billing continued without care. Admission and transfer records can place those disputed dates against the patient’s actual location and treatment status.
Staffing Records Can Change How the Government Reads the Claims
Dialysis treatment depends on nurses, technicians, physicians, and other staff working together. The number of treatments billed on a particular day can be compared against the personnel scheduled to deliver that care.
A facility reporting a large volume of treatments with limited clinical staff may face allegations that the reported services were impossible to perform. Limited staffing paired with shortened machine records or incomplete treatment notes can reinforce that allegation.
Schedules do not always capture the full workforce. Float staff, agency personnel, shift changes, or employees assigned across treatment areas may not appear clearly in a single roster. Payroll, badge access, and staffing assignments can show who was actually present and how the facility covered the disputed sessions.
High Treatment Volume Does Not Establish a Fraud Scheme
Large dialysis providers naturally generate substantial Medicare billing because ESRD patients require recurring treatment. Under the ESRD PPS, Medicare generally pays for up to three hemodialysis treatments per week unless additional treatments are medically justified.
Volume can still become part of the government’s case when a facility consistently reports more services than peer clinics or shows unusual treatment-frequency patterns. Those comparisons may lead prosecutors to identify certain patients or time periods for closer review.
A clinic treating medically unstable patients, recent hospital discharges, or patients transitioning between dialysis settings may produce utilization patterns that look unusual in aggregate data. Those numbers identify the pattern but not the clinical reason behind it. Reviewing the patient population alongside treatment frequency can show whether the volume reflects unusual billing or a different mix of medically complex cases.
Federal Healthcare Fraud Charges Require More Than a Billing Error
A disputed ESRD claim can become a criminal matter when prosecutors believe it formed part of a knowing and willful scheme. Under 18 U.S.C. § 1347, the government must prove that a person knowingly and willfully executed, or attempted to execute, a scheme to defraud a health care benefit program or obtain its money through false or fraudulent pretenses, representations, or promises.
An incorrect treatment date, classification error, or unsupported claim may justify repayment or further review without revealing who knew the information was wrong. Dialysis billing often moves through clinical staff, facility administrators, coders, and outside billing personnel before Medicare receives the claim.
A nephrologist who set the treatment plan but never selected the billing classification presents a different record from someone who controlled both the clinical documentation and the Medicare claim. Access to the billing platform, communications with coding staff, and approval authority can show how far the physician’s involvement actually extended.
The Treatment Timeline Can Show Who Controlled the Claim
A federal dialysis investigation can involve clinic owners, medical directors, nephrologists, nurses, administrators, and billing companies. Their roles may overlap, but their access to treatment and reimbursement information can be very different.
Patient records, machine logs, staffing data, claim histories, and internal communications can identify who knew that a treatment was shortened, missed, or performed differently from the way it appeared on the claim. They can also show whether the person accused of fraud ever saw the classification used for reimbursement.
When billing discrepancies are being used to build an ESRD fraud theory, working with a Florida healthcare fraud lawyer can place each disputed claim against the treatment record and the decisions behind its submission.
Contact The Baez Law Firm
If you are facing a federal investigation involving dialysis or ESRD billing, the government may be comparing treatment records with Medicare claims to determine whether services were misclassified or billed without being performed. The facts of each treatment session can look very different from the pattern created by claims data alone.
At The Baez Law Firm, we represent physicians, dialysis professionals, medical directors, and healthcare providers facing serious federal fraud allegations. Contact our firm today to speak with an experienced Florida healthcare fraud lawyer and learn how we can respond when ESRD billing discrepancies are being treated as evidence of intentional wrongdoing.
Sources:
- 18 U.S.C. § 1347 – Health Care Fraud
law.cornell.edu/uscode/text/18/1347 - Centers for Medicare & Medicaid Services – End-Stage Renal Disease Prospective Payment System
cms.gov/medicare/payment/prospective-payment-systems/end-stage-renal-disease-esrd - Centers for Medicare & Medicaid Services – ESRD PPS Consolidated Billing
cms.gov/medicare/payment/prospective-payment-systems/end-stage-renal-disease-esrd/esrd-pps-consolidated-billing - Centers for Medicare & Medicaid Services – Calendar Year 2026 End-Stage Renal Disease Prospective Payment System Final Rule
cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-end-stage-renal-disease-esrd-prospective-payment-system-final-rule - Centers for Medicare & Medicaid Services – End-Stage Renal Disease Prospective Payment System: July 2026 Quarterly Update
cms.gov/files/document/mm14483-esrd-prospective-payment-system-july-2026-quarterly-update.pdf
